ACG Issues Guidance on Celiac Disease Diagnosis and Management
The American College of Gastroenterology (ACG) has released new guidance on the diagnosis and management of celiac disease, a chronic autoimmune disorder triggered by gluten consumption. The comprehensive recommendations aim to improve the accuracy and efficiency of diagnosing the condition, which affects approximately 1% of the population. The guidelines emphasize the importance of using serologic tests as the initial step in screening for celiac disease, followed by endoscopic biopsy in selected cases. They also highlight the need for ongoing monitoring and follow-up care to ensure proper management of the disease. Additionally, the ACG guidance addresses key considerations such as the role of genetic testing, the impact of a gluten-free diet, and potential associated complications. Healthcare professionals and individuals with suspected or confirmed celiac disease can benefit from this evidence-based resource to enhance patient care and outcomes.